The Collaborative Research Group on Vaccines, Infections and Immunology (VIIM) will receive more than $ 4.5 million in NSW government funding over three years to study clinical and immunological responses to COVID-19 vaccines in NSW beneficiaries.
VIIM brings together the leading researchers and practitioners in vaccines, infections and immunology in New South Wales.
It integrates the expertise of two universities, four medical research institutes, the statewide pathology service, adult and pediatric health services and the National Center for Immunization Research and Surveillance.
Professor Tony Cunningham, director of the Center for Virus Research, The Westmead Institute for Medical Research, University of Sydney was a key figure in creating the initiative, said the collaboration will significantly strengthen research efforts to understand the virus. .
“We started this because we wanted to look at the comparison of vaccine immunity, and also natural immunity after COVID – we want to see how long it lasts, especially in aging subjects,” he said. declared. The Sydney Morning Herald.
Professor Kristine Macartney, University of Sydney and director of the National Center for Immunization Research and Surveillance, says that while extensive research into available vaccines is underway overseas, the deployment to NSW has been a unique opportunity to study COVID-19 vaccines with some of the world’s most comprehensive data on virus transmission, addressing the âtoughest questionsâ about vaccines in certain populations and facing new variants.
âWe cannot prevent COVID from entering. It’s in the world, and as we take action against the virus, we have to have the best science behind us, âshe said in an interview with The Sydney Morning Herald.
âWe are in a unique position. Because most of us have not been exposed to the virus, we are not immune and will depend heavily on the vaccine. “
Professor Robyn Ward, Pro Vice-Chancellor and Executive Dean of the Faculty of Medicine and Health said, âWe are delighted with this recognition and support of this crucial collaboration on the long-term impact of COVID-19, at a critical stage of managing the pandemic in Australia. It also highlights the breadth and level of expertise of several institutions, including the University of Sydney, and their contribution to solving some of the biggest questions around this virus. “